Deerfield Management’s 89bio ETNB Stock Holding History

Deerfield Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-506,100	Closed	-$1.63M	–	129
2022 Q2	$1.63M	Buy	+506,100	New	+$1.53M	0.03%	104

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Deerfield Management's ETNB Position: Q3 2022 in Review

Deerfield Management sold out of 89bio (ETNB) in Q3 2022, closing a stake of 506,100 shares — an estimated $1.63M sold.

Deerfield Management first reported a position in ETNB in Q2 2022 and held it in 1 quarter. The position peaked at $1.63M in Q2 2022. 86 funds tracked by Wall St. Rank hold ETNB as of Q3 2022.

Deerfield Management reported no remaining 89bio position as of Q3 2022 after selling out during the quarter.
Deerfield Management sold 506,100 89bio shares in Q3 2022, an estimated $1.63M.
Deerfield Management first reported a position in 89bio in Q2 2022 and held it in 1 quarter.
Deerfield Management's 89bio position peaked at $1.63M in Q2 2022.
86 funds tracked by Wall St. Rank held 89bio as of Q3 2022.

Based on Deerfield Management's 13F filing for Q3 2022, filed 14 Nov 2022.